RESEARCHER PROFILE

Jens Werner

← Back to Ludwig-Maximilians-Universität München

J

Ludwig-Maximilians-Universität München

Pancreatic and Hepatic Oncology ResearchPancreatitis Pathology and TreatmentGallbladder and Bile Duct DisordersCancer Immunotherapy and BiomarkersCholangiocarcinoma and Gallbladder Cancer Studies

Jens Werner works in Pancreatic and Hepatic Oncology Research, Pancreatitis Pathology and Treatment, Gallbladder and Bile Duct Disorders, Cancer Immunotherapy and Biomarkers, Cholangiocarcinoma and Gallbladder Cancer Studies. Recorded institutional associations include LMU Klinikum, University Hospital Regensburg, Ludwig-Maximilians-Universität München.

861Publications
28,684Citations
84H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. IAP Guidelines for the Surgical Management of Acute Pancreatitis

    2002 · 773 citations
  2. United European Gastroenterology evidence‐based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU)

    2017 · 711 citations
  3. Mitochondria and Mitochondrial ROS in Cancer: Novel Targets for Anticancer Therapy

    2016 · 672 citations
  4. β2 Adrenergic-Neurotrophin Feedforward Loop Promotes Pancreatic Cancer

    2017 · 534 citations
  5. IAP Guidelines for the surgical management of acute pancreatitis

    2002 · 534 citations
  6. Reactive Oxygen Species in the Immune System

    2013 · 509 citations
  7. Chronic pancreatitis

    2020 · 506 citations
  8. European experts consensus statement on cystic tumours of the pancreas

    2013 · 501 citations
  9. Pancreatic Cancer Surgery in the New Millennium

    2011 · 412 citations
  10. Management of acute pancreatitis: from surgery to interventional intensive care

    2005 · 407 citations
  11. Interventions for Necrotizing Pancreatitis

    2012 · 400 citations
  12. A Novel MIF Signaling Pathway Drives the Malignant Character of Pancreatic Cancer by Targeting NR3C2

    2016 · 393 citations
  13. Improvement of surgical results for pancreatic cancer

    2013 · 368 citations
  14. Cholinergic Signaling via Muscarinic Receptors Directly and Indirectly Suppresses Pancreatic Tumorigenesis and Cancer Stemness

    2018 · 360 citations
  15. Incisional hernia rate 3 years after midline laparotomy

    2013 · 355 citations
  16. Pancreatogastrostomy Versus Pancreatojejunostomy for RECOnstruction After PANCreatoduodenectomy (RECOPANC, DRKS 00000767)

    2015 · 334 citations
  17. CA19-9 in Potentially Resectable Pancreatic Cancer: Perspective to Adjust Surgical and Perioperative Therapy

    2012 · 301 citations
  18. Mechanisms of Metastasis in Colorectal Cancer and Metastatic Organotropism: Hematogenous versus Peritoneal Spread

    2019 · 298 citations
  19. Clinical Profile of Autoimmune Pancreatitis and Its Histological Subtypes

    2011 · 291 citations
  20. Perioperative Chemotherapy or Preoperative Chemoradiotherapy in Esophageal Cancer

    2025 · 286 citations
  21. The Role of Gut-Derived Lipopolysaccharides and the Intestinal Barrier in Fatty Liver Diseases

    2021 · 284 citations
  22. Impaired Autolysosome Formation Correlates With Lamp-2 Depletion: Role of Apoptosis, Autophagy, and Necrosis in Pancreatitis

    2009 · 246 citations
  23. A Simple Classification of Pancreatic Duct Size and Texture Predicts Postoperative Pancreatic Fistula

    2021 · 242 citations
  24. Pancreatic Adenocarcinoma

    2014 · 237 citations
  25. Sulforaphane targets pancreatic tumour-initiating cells by NF-κB-induced antiapoptotic signalling

    2008 · 229 citations

← Return to the university profile